Public Event Detail
CIMG Faces Heightened Nasdaq Delisting Risk After Filing Delay
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Historical observations only. No forecasts, recommendations, buy/sell ratings, or portfolio advice.
2026-03-03TSLATeslaAlpha Vantage Newsregulatory
Event summary
CIMG has received a notice from Nasdaq indicating that its failure to timely file its Form 10-Q for Q4 2025 will be an additional basis for potential delisting during their existing monitoring period. This heightens regulatory pressure on the digital health and crypto-focused company, which is already under a Mandatory Panel Monitor since December 2025. Analysts currently rate the stock as a Sell with a $0.50 price target.
Attached public signals
Observed outcomes
7d returnPending
30d returnPending
90d returnPending
Relative 90d returnPending